Novenda Technologies secures $6.1m to revolutionise dental products with breakthrough 3D printing
Novenda Technologies has announced $6.1m in funding to transform dental product manufacturing with its revolutionary multi-material 3D printing technology.
This innovative solution aims to make high-quality dental care better, more aesthetically pleasing, accessible and affordable.
The $6.1m Series A funding round was led by Brightlands Venture Partners with participation from KBC Focus Fund (Belgium), Borski Fund (NL) and Limburg Business Development Fund/LIOF (NL) as well as a group of angel investors and an Innovation Credit from RVO.
Klaas Wiertzema, CEO and co-founder of Novenda Technologies said: “The combination of water-soluble support and the absence of mechanical interventions to compensate for imprecisions ensures unprecedented long-term accuracy and eliminates the need for extensive post-processing.
“This is particularly important in a world where dental technicians are becoming increasingly scarce and expensive.”
The company’s full stack technology enables the manufacturing of more comfortable, natural-looking dental products that combine hard materials for protection with soft materials for comfort – all in a single piece.
While traditional methods require manual assembly and post-processing, the company’s platform combines multiple materials seamlessly in a single print run, using water-soluble supports that dissolve with a simple tap water wash.
Most significantly, Novenda Technologies has developed smart print modes that achieve precise layer control without mechanical rollers – a limitation that causes ink contamination and restricted colour capabilities in competing systems.
The platform’s impact is already evident. Its innovative colour management algorithm achieves unlimited colour possibilities using just a few base colours, while maintaining superior mechanical properties that ensure products won’t break during use.
The system can produce up to 15 nightguards and 8 dentures per hour, making it ideal for mid-size and large dental labs.
While Novenda’s LD100 printer represents a one-time investment, the LD100 works exclusively with its own materials to ensure quality and biocompatibility, generating recurring revenue while maintaining strict quality standards.
Olga Goor, Investment Manager at Brightlands Venture Partners, said: “As lead investor, Brightlands Venture Partners is proud to support Novenda Technologies in this next phase of growth.
“Their multi-material jetting technology is a breakthrough in digital dentistry, enabling scalable, high-precision manufacturing with minimal waste and post-processing.
“This innovation not only sets a new quality standard for dental products but also enhances affordability of dental care for patients that are unable to afford alternatives currently available in the market.
“This will ultimately drive the transformation of the dental industry towards a more sustainable and equitable future.”
Looking ahead, Novenda plans to expand its platform to other dental applications and eventually enter new markets where individualised mass manufacturing is key.
The company’s immediate focus is on deploying its technology in large and mid size dental labs across Europe and the US, where its high-throughput, automated solution can help meet growing demand.
